| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
| mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-07 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-07 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0002 |